Source:http://linkedlifedata.com/resource/pubmed/id/15683552
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2005-2-1
|
pubmed:abstractText |
P-glycoprotein (P-gp) in the brain capillary endothelial cell limits the entry of many drugs into the brain. Our previous in-vitro study using ATPase as a marker of P-gp activity suggested that risperidone might be effectively transported by P-gp. In the present study, we compared the concentrations of risperidone and its major pharmacologically active metabolite 9-hydroxyrisperidone (9-OH-risperidone), in plasma, brain and various other tissues between abcb1ab-/- knockout mice which are functionally devoid of P-gp in their blood-brain barrier vs. FVB wild-type mice. One hour after intraperitoneal injection of 4 microg/g risperidone, the brain concentrations and ratios of brain:plasma concentrations of risperidone (13.1-fold and 12-fold respectively, p<0.05) and 9-OH-risperidone (29.4-fold and 29-fold respectively, p<0.01) were significantly higher in the abcb1ab-/- mice than those in the FVB mice. These results indicate that P-gp in the blood-brain barrier significantly influences the brain concentrations of risperidone and 9-OH-risperidone by limiting their CNS access.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/9-hydroxy-risperidone,
http://linkedlifedata.com/resource/pubmed/chemical/Isoxazoles,
http://linkedlifedata.com/resource/pubmed/chemical/P-Glycoprotein,
http://linkedlifedata.com/resource/pubmed/chemical/Pyrimidines,
http://linkedlifedata.com/resource/pubmed/chemical/Risperidone,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin Antagonists
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1461-1457
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
415-9
|
pubmed:dateRevised |
2007-11-14
|
pubmed:meshHeading |
pubmed-meshheading:15683552-Animals,
pubmed-meshheading:15683552-Brain,
pubmed-meshheading:15683552-Chromatography, High Pressure Liquid,
pubmed-meshheading:15683552-Injections, Intraperitoneal,
pubmed-meshheading:15683552-Isoxazoles,
pubmed-meshheading:15683552-Male,
pubmed-meshheading:15683552-Mice,
pubmed-meshheading:15683552-Mice, Transgenic,
pubmed-meshheading:15683552-P-Glycoprotein,
pubmed-meshheading:15683552-Pyrimidines,
pubmed-meshheading:15683552-Risperidone,
pubmed-meshheading:15683552-Serotonin Antagonists,
pubmed-meshheading:15683552-Tissue Distribution
|
pubmed:year |
2004
|
pubmed:articleTitle |
The brain entry of risperidone and 9-hydroxyrisperidone is greatly limited by P-glycoprotein.
|
pubmed:affiliation |
Laboratory of Drug Disposition and Pharmacogenetics, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC 29425, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|